Delivery Order SPE2DB20D3103-SPE2DB25FP1B2

Award Date 6/10/25
Potential Completion Date 6/11/25
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a pharmaceutical product, with a firm fixed price of $2,601.43 and a period of performance through May 23, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the medication FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, with a ceiling value of $10,405.72 and a period of performance through June 9, 2025. The contract is a firm-fixed price type and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a $1,272.03 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication. The order has an ultimate completion date of January 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication, with a ceiling value of $8,666.46. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, with a ceiling value of $2,601.43. It is a firm-fixed-price contract with a completion date of June 12, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,908.92, is for the delivery of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication. The contract has an ultimate completion date of April 1, 2025 and is a firm fixed-price contract. This contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of medical products including the drug FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML. The contract has a ceiling value of $32,141.18 and is a firm fixed price arrangement with a performance period ending on June 13, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,833.32, is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a pharmaceutical product. The contract has a period of performance through March 17, 2025 and is a firm fixed-price contract. No set-aside designation is mentioned. AmerisourceBergen holds a larger Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a pharmaceutical product, with a ceiling value of $176,829.66 and a period of performance through May 19, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty pharmaceutical product. The contract has a ceiling value of $1,833.32 and a completion date of February 13, 2025. It is a firm fixed price contract awarded without a set-aside designation, indicating open competition. AmerisourceBergen...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FP1B2
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a prescription medication. The contract has a firm fixed price, with a ceiling value of $2,601.43, and a performance period extending through June 11, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 9/14/25, 1:00 AM